SP600125 promotes resolution of allergic airway inflammation via TLR9 in an OVA-induced murine acute asthma model

Molecular Immunology

Volumn 67, Issue 2, 2015, Pages 311-316

  Wu, Hui Mei ^a   Fang, Lei ^a   Shen, Qi Ying ^a   Liu, Rong Yu ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Acute asthma; Allergic airway inflammation; JNK; SP600125; TLR9

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; IMMUNOGLOBULIN E; INTERLEUKIN 10; OVALBUMIN; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; CYTOKINE;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; EOSINOPHIL COUNT; FEMALE; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATORY CELL; LUNG LAVAGE; LUNG PARENCHYMA; LYMPHOCYTE COUNT; MONOCYTE; MOUSE; MUCUS SECRETION; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ACUTE DISEASE; ANIMAL; BLOOD; BRONCHOALVEOLAR LAVAGE FLUID; C57BL MOUSE; CELL COUNT; COMPLICATION; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; HYPERSENSITIVITY; INFLAMMATION; LUNG; METABOLISM; MUCUS; PATHOLOGY; PHOSPHORYLATION; SECRETION (PROCESS);

ACUTE DISEASE; ANIMALS; ANTHRACENES; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INFLAMMATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG; MICE, INBRED C57BL; MUCUS; OVALBUMIN; PHOSPHORYLATION; TOLL-LIKE RECEPTOR 9;

EID: 84940953236     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2015.06.016     Document Type: Article

References (35)

1. Adner M., Starkhammar M., Georen S.K., Dahlen S.E., Cardell L.O. Toll-like receptor (TLR) 7 decreases and TLR9 increases the airway responses in mice with established allergic inflammation. Eur. J. Pharmacol. 2013, 718:544-551.
2. Aryan Z., Holgate S.T., Radzioch D., Rezaei N. A new era of targeting the ancient gatekeepers of the immune system: toll-like agonists in the treatment of allergic rhinitis and asthma. Int. Arch. Allergy Immunol. 2014, 164:46-63.
3. Beeh K.M., Kanniess F., Wagner F., Schilder C., Naudts I., Hammann-Haenni A., Willers J., Stocker H., Mueller P., Bachmann M.F., Renner W.A. The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma. J. Allergy Clin. Immunol. 2013, 131:866-874.
4. Bennett B.L. c-Jun N-terminal kinase-dependent mechanisms in respiratory disease. Eur. Respir. J. 2006, 28:651-661.
5. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13681-13686.
6. Camateros P., Tamaoka M., Hassan M., Marino R., Moisan J., Marion D., Guiot M.C., Martin J.G., Radzioch D. Chronic asthma-induced airway remodeling is prevented by toll-like receptor-7/8 ligand S28463. Am. J. Respir. Crit. Care Med. 2007, 175:1241-1249.
7. Caramori G., Groneberg D., Ito K., Casolari P., Adcock I.M., Papi A. New drugs targeting Th2 lymphocytes in asthma. J. Occup. Med. Toxicol. 2008, 3(Suppl. 1):S6.
8. Duan W., Wong W.S. Targeting mitogen-activated protein kinases for asthma. Curr. Drug Targets 2006, 7:691-698.
9. Duechs M.J., Hahn C., Benediktus E., Werner-Klein M., Braun A., Hoymann H.G., Gantner F., Erb K.J. TLR agonist mediated suppression of allergic responses is associated with increased innate inflammation in the airways. Pulm. Pharmacol. Ther. 2011, 24:203-214.
10. Eynott P.R., Nath P., Leung S.Y., Adcock I.M., Bennett B.L., Chung K.F. Allergen-induced inflammation and airway epithelial and smooth muscle cell proliferation: role of Jun N-terminal kinase. Br. J. Pharmacol. 2003, 140:1373-1380.
11. Eynott P.R., Xu L., Bennett B.L., Noble A., Leung S.Y., Nath P., Groneberg D.A., Adcock I.M., Chung K.F. Effect of an inhibitor of Jun N-terminal protein kinase, SP600125, in single allergen challenge in sensitized rats. Immunology 2004, 112:446-453.
12. Geha R.S., Jabara H.H., Brodeur S.R. The regulation of immunoglobulin E class-switch recombination. Nat. Rev. Immunol. 2003, 3:721-732.
13. Holley M.M., Zhang Y., Lehrmann E., Wood W.H., Becker K.G., Kielian T. Toll-like receptor 2 (TLR2)-TLR9 crosstalk dictates IL-12 family cytokine production in microglia. Glia 2012, 60:29-42.
14. Hommes D.W., Peppelenbosch M.P., van Deventer S.J. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 2003, 52:144-151.
15. Jabara H.H., Geha R.S. Jun N-terminal kinase is essential for CD40-mediated IgE class switching in B cells. J. Allergy Clin. Immunol. 2005, 115:856-863.
16. Kim H.R., Lee D.M., Lee S.H., Seong A.R., Gin D.W., Hwang J.A., Park J.H. Chlorogenic acid suppresses pulmonary eosinophilia, IgE production, and Th2-type cytokine production in an ovalbumin-induced allergic asthma: activation of STAT-6 and JNK is inhibited by chlorogenic acid. Int. Immunopharmacol. 2010, 10:1242-1248.
17. Koltsida O., Karamnov S., Pyrillou K., Vickery T., Chairakaki A.D., Tamvakopoulos C., Sideras P., Serhan C.N., Andreakos E. Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation. EMBO Mol. Med. 2013, 5:762-775.
18. Lane S.J., Adcock I.M., Richards D., Hawrylowicz C., Barnes P.J., Lee T.H. Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes. J. Clin. Invest. 1998, 102:2156-2164.
19. Larche M., Robinson D.S., Kay A.B. The role of T lymphocytes in the pathogenesis of asthma. J. Allergy Clin. Immunol. 2003, 111:450-463. (quiz 464).
20. Lee I.T., Liu S.W., Chi P.L., Lin C.C., Hsiao L.D., Yang C.M. TNF-alpha mediates PKCdelta/JNK1/2/c-Jun-dependent monocyte adhesion via ICAM-1 induction in human retinal pigment epithelial cells. PLOS ONE 2015, 10:e0117911.
21. Lin Y.C., Huang D.Y., Chu C.L., Lin W.W. Anti-inflammatory actions of Syk inhibitors in macrophages involve non-specific inhibition of toll-like receptors-mediated JNK signaling pathway. Mol. Immunol. 2010, 47:1569-1578.
22. Locke N.R., Royce S.G., Wainewright J.S., Samuel C.S., Tang M.L. Comparison of airway remodeling in acute, subacute, and chronic models of allergic airways disease. Am. J. Respir. Cell Mol. Biol. 2007, 36:625-632.
23. Mitchell D., Olive C. Regulation of Toll-like receptor-induced chemokine production in murine dendritic cells by mitogen-activated protein kinases. Mol. Immunol. 2010, 47:2065-2073.
24. Morton S., Davis R.J., McLaren A., Cohen P. A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J. 2003, 22:3876-3886.
25. Nath P., Eynott P., Leung S.Y., Adcock I.M., Bennett B.L., Chung K.F. Potential role of c-Jun NH2-terminal kinase in allergic airway inflammation and remodelling: effects of SP600125. Eur. J. Pharmacol. 2005, 506:273-283.
26. Ramaprakash H., Hogaboam C.M. Intranasal CpG therapy attenuated experimental fungal asthma in a TLR9-dependent and -independent manner. Int. Arch. Allergy Immunol. 2010, 152:98-112.
27. Roux P.P., Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 2004, 68:320-344.
28. Sanchez-Zauco N., Del Rio-Navarro B., Gallardo-Casas C., Del Rio-Chivardi J., Muriel-Vizcaino R., Rivera-Pazos C., Huerta-Yepez S., Cruz-Lopez M., Maldonado-Bernal C. High expression of Toll-like receptors 2 and 9 and Th1/Th2 cytokines profile in obese asthmatic children. Allergy Asthma Proc. 2014, 35:34-41.
29. Tsai C.Y., Lu S.L., Hu C.W., Yeh C.S., Lee G.B., Lei H.Y. Size-dependent attenuation of TLR9 signaling by gold nanoparticles in macrophages. J. Immunol. 2012, 188:68-76.
30. van der Velden J.L., Hoffman S.M., Alcorn J.F., Tully J.E., Chapman D.G., Lahue K.G., Guala A.S., Lundblad L.K., Aliyeva M., Daphtary N., Irvin C.G., Janssen-Heininger Y.M. Absence of c-Jun NH2-terminal kinase 1 protects against house dust mite-induced pulmonary remodeling but not airway hyperresponsiveness and inflammation. Am. J. Physiol. Lung Cell Mol. Physiol. 2014, 306:L866-L875.
31. Van Seuningen I., Perrais M., Pigny P., Porchet N., Aubert J.P. Sequence of the 5'-flanking region and promoter activity of the human mucin gene MUC5B in different phenotypes of colon cancer cells. Biochem. J. 2000, 348(Pt 3):675-686.
32. Volpi C., Fallarino F., Pallotta M.T., Bianchi R., Vacca C., Belladonna M.L., Orabona C., De Luca A., Boon L., Romani L., Grohmann U., Puccetti P. High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. Nat. Commun. 2013, 4:1852.
33. Xie S., Sukkar M.B., Issa R., Oltmanns U., Nicholson A.G., Chung K.F. Regulation of TGF-beta 1-induced connective tissue growth factor expression in airway smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2005, 288:L68-L76.
34. Xirakia C., Koltsida O., Stavropoulos A., Thanassopoulou A., Aidinis V., Sideras P., Andreakos E. Toll-like receptor 7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma. Am. J. Respir. Crit. Care Med. 2010, 181:1207-1216.
35. Zhai W., Eynott P.R., Oltmanns U., Leung S.Y., Chung K.F. Mitogen-activated protein kinase signalling pathways in IL-1 beta-dependent rat airway smooth muscle proliferation. Br. J. Pharmacol. 2004, 143:1042-1049.